1-19 of 19
| Supplier | Product name | Cat.no. | Pack size | Price | ||
|---|---|---|---|---|---|---|
 |
In Vivo Grade Recombinant Human IgG4 Fc Protein | BP4093-1MG | 569,00 |
|
||
|
|
Nivolumab Biosimilar, Human PD-1 Monoclonal Antibody | C026P-1MG | 221,00 |
|
||
|
|
Pembrolizumab Biosimilar, Human PD-1 Monoclonal Antibody | C027P-1MG | 221,00 |
|
||
|
|
Ipilimumab Biosimilar, Human CTLA-4 Monoclonal Antibody | C050P-1MG | 221,00 |
|
||
|
|
In Vivo Grade Recombinant Human IgG4-S228P Isotype Control Antibody | PA007128-1MG | 192,00 |
|
||
|
|
In Vivo Grade Recombinant Human IgG4-S228P L235E P329G (SPLEPG) Isotype Control Antibody | PA007131-1MG | 204,00 |
|
||
|
|
In vivo Grade Recombinant Humanized HEL D1.3 Human IgG4-S228P Isotype Control Antibody | PA007153.h4-5MG | 414,00 |
|
||
|
|
In vivo Grade Recombinant Humanized HyHEL-10 Human IgG4-S228P Isotype Control Antibody | PA007154.h4-5MG | 414,00 |
|
||
|
|
Cetuximab Biosimilar, Human IgG4 S228P Mutant | C002P.4S-0.5MG | 440,00 |
|
1-19 of 19
Customer Support
T +41 41 420 96 36
F +41 41 420 96 56
info@lucerna-chem.ch
Business Hours
Monday to Friday
08:00 – 12:00
13:00 – 17:00
Technical Support
tech@lucerna-chem.ch
Business Development
business.dev@lucerna-chem.ch
Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern
© Copyright 2021 Lucerna-Chem AG, Switzerland